Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Deepa S. Mandlik & Satish K. Mandlik. (2020) New perspectives in bronchial asthma: pathological, immunological alterations, biological targets, and pharmacotherapy. Immunopharmacology and Immunotoxicology 42:6, pages 521-544.
Read now
Read now
Patrick Mitchell & Richard Leigh. (2019) A drug safety review of treating eosinophilic asthma with monoclonal antibodies. Expert Opinion on Drug Safety 18:12, pages 1161-1170.
Read now
Read now
Mario Cazzola, Maria Gabriella Matera, Francesca Levi-Schaffer & Paola Rogliani. (2018) Safety of humanized monoclonal antibodies against IL-5 in asthma: focus on reslizumab. Expert Opinion on Drug Safety 17:4, pages 429-435.
Read now
Read now
Maria Gabriella Matera, Paola Rogliani, Luigino Calzetta & Mario Cazzola. (2018) Pharmacokinetic/pharmacodynamic profile of reslizumab in asthma. Expert Opinion on Drug Metabolism & Toxicology 14:2, pages 239-245.
Read now
Read now
J. Mark FitzGerald, Catherine Lemiere, M. Diane Lougheed, Francine M. Ducharme, Sharon D. Dell, Clare Ramsey, M. Connie L. Yang, Andréanne Côté, Wade Watson, Ron Olivenstein, Anne Van Dam, Cristina Villa-Roel & Roland Grad. (2017) Recognition and management of severe asthma: A Canadian Thoracic Society position statement. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 1:4, pages 199-221.
Read now
Read now
Articles from other publishers (20)
Ming-Li Chen, Tanawin Nopsopon & Ayobami Akenroye. (2023) Incidence of Anti-Drug Antibodies to Monoclonal Antibodies in Asthma: A Systematic Review and Meta-Analysis. The Journal of Allergy and Clinical Immunology: In Practice 11:5, pages 1475-1484.e20.
Crossref
Crossref
Johannes A. Kroes, Rafael Alfonso-Cristancho, Aruna T. Bansal, Emmanuelle Berret, Kristina Bieksiene, Arnaud Bourdin, Luisa Brussino, Diogo Canhoto, Cristina Cardini, Gulfem Celik, Zsuzsanna Csoma, Barbro Dahlén, Ebru Damadoglu, Katrien Eger, Lisa Gauquelin, Bilun Gemicioglu, Ozlem Goksel, Sophie Graff, Enrico Heffler, Hendrik B. Hofstee, Peter Howarth, Rupert W. Jakes, Fabienne Jaun, Virginija Kalinauskaite-Zukauske, Peter Kopač, Namhee Kwon, Claudia C. Loureiro, Victor Lozoya García, Matthew Masoli, Mariana Paula Rezelj, Luis Pérez De Llano, Sanja Popović-Grle, David Ramos-Barbón, Ana Sà Sousa, Konstantinos Samitas, Florence Schleich, Concetta Sirena, Sabina Skrgat, Eleftherios Zervas, George Zichnalis, Elisabeth H. Bel, Jacob K. Sont, Simone Hashimoto & Anneke Ten Brinke. (2023) Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis. ERJ Open Research 9:2, pages 00745-2022.
Crossref
Crossref
Hugo A Farne, Amanda Wilson, Stephen Milan, Emma Banchoff, Freda Yang & Colin VE Powell. (2022) Anti-IL-5 therapies for asthma. Cochrane Database of Systematic Reviews 2022:7.
Crossref
Crossref
David Charles, Jemma Shanley, Sasha‐Nicole Temple, Anna Rattu, Ekaterina Khaleva & Graham Roberts. (2022) Real‐world efficacy of treatment with benralizumab, dupilumab, mepolizumab and reslizumab for severe asthma: A systematic review and meta‐analysis. Clinical & Experimental Allergy 52:5, pages 616-627.
Crossref
Crossref
Gabriel García, Miguel Bergna, Juan C. Vásquez, Maria C. Cano Salas, José L. Miguel, Carlos Celis Preciado, Agustin Acuña Izcaray, Manuel Barros Monge, Natalia García Batista, Ignacio Zabert, José L. Mayorga, Renato Casanova Mendoza, Martha Gutierrez, Maria F. Montero Arias, Luzcenelia Urtecho Perez, Miguel Antúnez, Victoria Williams Derby, Alejandra Villatoro Azméquita, Luis Motiño, M. Alenita De Oliveira, Diana Rey Sanchez, Marisol Arroyo & Mario Rodriguez. (2021) Severe asthma: adding new evidence – Latin American Thoracic Society. ERJ Open Research 7:1, pages 00318-2020.
Crossref
Crossref
Ioana Agache, Jessica Beltran, Cezmi Akdis, Mubeccel Akdis, Carlos Canelo‐Aybar, Giorgio Walter Canonica, Thomas Casale, Tomas Chivato, Jonathan Corren, Stefano Del Giacco, Thomas Eiwegger, Davide Firinu, James E. Gern, Eckard Hamelmann, Nicola Hanania, Mika Mäkelä, Irene Hernández‐Martín, Parameswaran Nair, Liam O'Mahony, Nikolaos G. Papadopoulos, Alberto Papi, Hae‐Sim Park, Luis Pérez de Llano, Margarita Posso, Claudio Rocha, Santiago Quirce, Joaquin Sastre, Mohamed Shamji, Yang Song, Corinna Steiner, Jurgen Schwarze, Pablo Alonso‐Coello, Oscar Palomares & Marek Jutel. (2020) Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma. Allergy 75:5, pages 1023-1042.
Crossref
Crossref
J. Christian Virchow, Rohit Katial, Guy G. Brusselle, Yael Shalit, Margaret Garin, Mirna McDonald & Mario Castro. (2020) Safety of Reslizumab in Uncontrolled Asthma with Eosinophilia: A Pooled Analysis from 6 Trials. The Journal of Allergy and Clinical Immunology: In Practice 8:2, pages 540-548.e1.
Crossref
Crossref
Amelia Licari, Riccardo Castagnoli, Enrico Tondina, Giorgia Testa, Giuseppe Fabio Parisi, Alessia Marseglia, Ilaria Brambilla & Gian Luigi Marseglia. (2020) Novel Biologics for the Treatment of Pediatric Severe Asthma. Current Respiratory Medicine Reviews 15:3, pages 195-204.
Crossref
Crossref
Elissa M. Abrams, Heather E. Hoch, Allan B. Becker & Stanley J. Szefler. 2020. Severe Asthma in Children and Adolescents. Severe Asthma in Children and Adolescents
287
312
.
Pierachille Santus, Marina Saad, Giovanni Damiani, Vincenzo Patella & Dejan Radovanovic. (2019) Current and future targeted therapies for severe asthma: Managing treatment with biologics based on phenotypes and biomarkers. Pharmacological Research 146, pages 104296.
Crossref
Crossref
Laurent Guilleminault & Alain Didier. (2019) L’asthme sévère à l’ère des biothérapies. La Presse Médicale 48:3, pages 310-321.
Crossref
Crossref
Christina G. Kwong & Jeffrey R. Stokes. 2019. Allergy and Asthma. Allergy and Asthma
961
981
.
Elissa M. AbramsAllan B. BeckerStanley J. Szefler. (2018) Current State and Future of Biologic Therapies in the Treatment of Asthma in Children. Pediatric Allergy, Immunology, and Pulmonology 31:3, pages 119-131.
Crossref
Crossref
Dolly V. Rojas, Diana L. Silva & Carlos D. Serrano. 2018. Asthma Diagnosis and Management - Approach Based on Phenotype and Endotype. Asthma Diagnosis and Management - Approach Based on Phenotype and Endotype.
Vasiliki Delimpoura, Clementine Bostantzoglou, Norrice Liu & Raffaella Nenna. (2018) Novel therapies for severe asthma in children and adults. Breathe 14:1, pages 59-62.
Crossref
Crossref
Marc Humbert, William Busse & Nicola A. Hanania. (2018) Controversies and opportunities in severe asthma. Current Opinion in Pulmonary Medicine 24:1, pages 83-93.
Crossref
Crossref
Christina G. Kwong & Jeffrey R. Stokes. 2018. Allergy and Asthma. Allergy and Asthma
1
21
.
Hugo A Farne, Amanda Wilson, Colin Powell, Lynne Bax & Stephen J Milan. (2017) Anti-IL5 therapies for asthma. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Marie-Chantal Larose, Anne-Sophie Archambault, Véronique Provost, Michel Laviolette & Nicolas Flamand. (2017) Regulation of Eosinophil and Group 2 Innate Lymphoid Cell Trafficking in Asthma. Frontiers in Medicine 4.
Crossref
Crossref
Zhigang Wang, Zhe Chen, Tao Chen, Tao Yi, Zhou Zheng, Hong Fan & Zebin Chen. (2016) Berberine Attenuates Inflammation Associated with Delayed-Type Hypersensitivity via Suppressing Th1 Response and Inhibiting Apoptosis. Inflammation 40:1, pages 221-231.
Crossref
Crossref